文献速递认知障碍与痴呆

TDP-43与隐匿RNA与阿尔茨海默病海马及杏仁核体积的生化与免疫组化关联

Biochemical and Immunohistochemical Associations of TDP-43 and Cryptic RNA With Hippocampal and Amygdala Volumetrics in Alzheimer's Disease.
PubMed 文献 · Ann Neurol · 2026-04-08

结果显示MSD-TDP水平可可靠替代IHC-TDP状态,TDP-43与隐匿RNA水平均与内侧颞叶体积减小相关,提示隐匿外显子可能参与AD脑体积丢失。

要点

  • MSD-TDP水平可作为IHC-TDP状态的可靠替代指标
  • IHC-TDP阳性者海马和杏仁核体积更小
  • 隐匿RNA水平升高与杏仁核体积减小相关

核心结论

  • MSD-TDP水平是IHC-TDP状态的可靠替代指标,TDP-43与隐匿RNA水平均与内侧颞叶体积减小相关,提示隐匿外显子可能参与AD脑体积丢失。

主要发现

  • IHC-TDP阳性病例海马和杏仁核中MSD-TDP及隐匿RNA(KCNQ2、STMN2、UNC13A)水平升高,且MSD-TDP水平升高与隐匿RNA水平升高相关。
  • IHC-TDP阳性病例较IHC-TDP阴性病例海马和杏仁核体积更小。
  • MSD-TDP阳性病例较MSD-TDP阴性病例海马体积更小且杏仁核萎缩速率更快。
  • 较高的KCNQ2和UNC13A水平与较小的杏仁核体积相关。

临床怎么用

  • MSD-TDP检测或可作为IHC-TDP状态的替代方法用于AD病理评估。
  • TDP-43及隐匿RNA水平可能有助于提示AD患者内侧颞叶体积丢失风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Immunohistochemically (IHC) measured transactive response DNA-binding protein 43 (TDP-43) inclusions are observed in Alzheimer's disease (AD) and are associated with medial temporal lobe atrophy. Accumulation of cryptic exons occurs in AD in response to TDP-43 pathology. We aimed to assess relationships between IHC and biochemically measured insoluble TDP-43 and cryptic exons and assess associations with hippocampal and amygdala volume loss and atrophy rates on magnetic resonance imaging (MRI). METHODS: Eighty-one neuropathologically diagnosed AD cases were analyzed. For biochemistry, insoluble TDP-43 was quantified using a Meso-scale discovery (MSD) immunoassay. IHC-TDP burden was quantified with digital histopathology. Cryptic RNAs were assessed via quantitative real-time polymerase chain reaction (qRT-PCR). Thirty-eight cases had serial brain MRI. Hippocampal and amygdala volumes were calculated using FreeSurfer. Regression models were used to investigate associations among IHC-TDP-43 status/burden, MSD-TDP status/levels, cryptic RNAs, and hippocampal and amygdala volumes and atrophy rates. RESULTS: IHC-TDP(+) cases exhibited elevated levels of MSD-TDP and cryptic RNAs (KCNQ2, STMN2, and UNC13A) and increased MSD-TDP levels were associated with increased cryptic RNA levels, in the hippocampus and amygdala. IHC-TDP(+) cases had smaller hippocampal and amygdala volumes compared to IHC-TDP(-) cases. MSD-TDP(+) cases had smaller hippocampal volumes and faster amygdala rates of atrophy compared with MSD-TDP(-) cases. Higher KCNQ2 and UNC13A levels were associated with smaller amygdala volumes. INTERPRETATION: MSD-TDP level is a reliable surrogate for IHC-based TDP-43 status. Both TDP-43 and cryptic RNA levels are associated with reduced medial temporal volumes, suggesting cryptic exons may be playing a role in brain volume loss in AD. ANN NEUROL 2026;100:193-205.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Youssef H, Gatto RG, Ghayal NB, et al. Biochemical and Immunohistochemical Associations of TDP-43 and Cryptic RNA With Hippocampal and Amygdala Volumetrics in Alzheimer's Disease. Ann Neurol. 2026. PMID: 41952326. doi:10.1002/ana.78223

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。